Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Munch-a-Biotech Today -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (314)	3/30/1999 11:44:00 AM
From: Biomaven	Read Replies (1) \| Respond to of 3158

Rick, Any sense if this is going to be the first of many such licenses? Just how broad are these patents? How would SIBI discover that something was discovered using technology that infringed the patents? I suppose big pharma might choose to cough up a minimal royalty up front rather than risk the discovery after a product was commercialized that it was discovered using infringing technology. I guess the PDLI Queen patent is a little analogous, but enforcement is much easier there as PDLI can presumably figure out fairly easily if a new product is infringing. Peter